Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.

Kim, Bokyung; Jung, Jin-Hyung; Han, Kyungdo; Kang, Seungkyung; Lee, Eunwoo; Chung, Hyunsoo; Kim, Sang Gyun; Cho, Soo-Jeong

Kim, Bokyung; Jung, Jin-Hyung; Han, Kyungdo; Kang, Seungkyung; Lee, Eunwoo; Chung, Hyunsoo; Kim, Sang Gyun; Cho, Soo-Jeong.

Afiliação

Kim B; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Jung JH; Department of Biostatistics, The Catholic University College of Medicine, Seoul, Korea.
Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
Kang S; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Lee E; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Chung H; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Kim SG; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Cho SJ; Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. crystal522@daum.net.

J Korean Med Sci ; 38(13): e99, 2023 Apr 03.

Article em En | MEDLINE | ID: mdl-37012686

Assuntos

COVID-19; Diabetes Mellitus; Dislipidemias; Hipertensão; Humanos; Inibidores da Bomba de Prótons/uso terapêutico; Estudos de Coortes; SARS-CoV-2; Histamina; Pontuação de Propensão; Diabetes Mellitus/epidemiologia; Antagonistas dos Receptores H2 da Histamina/uso terapêutico; Hipertensão/tratamento farmacológico; Hipertensão/epidemiologia; Dislipidemias/complicações; Dislipidemias/tratamento farmacológico; Dislipidemias/epidemiologia

Palavras-chave

COVID-19; Histamine H2 Antagonists; Proton Pump Inhibitors; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Dislipidemias / COVID-19 / Hipertensão Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google